Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
52°
Rain
Toggle navigation
Menu
Subscribe
Home
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Oncolytics Biotech Inc
(TSX:
ONC
)
3.620
CAD
+0.020 (+0.56%)
Streaming Delayed Price
Updated: 3:59 PM EST, Jan 20, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Oncolytics Biotech Inc
< Previous
1
2
3
4
5
6
Next >
Pelareorep Along With Checkpoint Inhibitors Proving Critically Important for Early Stage Breast Cancer
December 09, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Pelareorep Along With Checkpoint Inhibitors Proving Critically Important for Early Stage Breast Cancer
December 09, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Oncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer Symposium
December 09, 2020
Tags
ONCY News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer Symposium
December 09, 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) and SOLTI-Innovative Breast Cancer Research today published an electronic poster at the 2020 San Antonio Breast Cancer Symposium (SABCS) with data...
From
PR Newswire
Thinking about buying stock in Pfizer, Nio, Lexicon Pharmaceuticals, Oncolytics Biotech, or Boeing?
December 08, 2020
InvestorsObserver issues critical PriceWatch Alerts for PFE, NIO, LXRX, ONCY, and BA.
From
PR Newswire
Thinking about buying stock in Oncolytics Biotech, Virgin Galactic, American Airlines, Norwegian Cruise Line, or Intel Corp?
December 07, 2020
InvestorsObserver issues critical PriceWatch Alerts for ONCY, SPCE, AAL, NCLH, and INTC.
From
PR Newswire
New Pharma Trials Making Big Gains in Fight Against Triple-Negative Breast Cancer (TNBC)
December 02, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
New Pharma Trials Making Big Gains in Fight Against Triple-Negative Breast Cancer (TNBC)
December 02, 2020
FN Media Group Presents USA News Group News Commentary
From
PR Newswire
Oncolytics Biotech® Announces Positive Clinical Results Against Glioblastoma Multiforme at the 2020 Society of Neuro-Oncology Annual Meeting
November 19, 2020
Pelareorep delivers efficacy, safety, and tolerability in difficult-to-treat GBM
From
PR Newswire
Oncolytics Biotech® to Present AWARE-1 Data and Provide Updates on Phase 2 BRACELET-1 and IRENE Trials at the 2020 San Antonio Breast Cancer Symposium
November 17, 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the publication of three abstracts for electronic poster presentations to be given as part of the 2020 San Antonio Breast Cancer...
From
PR Newswire
Oncolytics Biotech® Reports 2020 Third Quarter Development Highlights and Financial Results
November 11, 2020
Recently announced AWARE-1 data further support the potential of pelareorep to induce a durable anti-tumor immune memory effect and improve outcomes in breast cancer
From
PR Newswire
Biotech Brief: Breast Cancer Drug Market Could Exceed $38 Billion By 2025
November 09, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotech Brief: Breast Cancer Drug Market Could Exceed $38 Billion By 2025
November 09, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Oncolytics Biotech® and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at The Society for Immunotherapy of Cancer Annual Meeting
November 09, 2020
Tags
ONCY News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at The Society for Immunotherapy of Cancer Annual Meeting
November 09, 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) and SOLTI-Innovative Breast Cancer Research today announced the publication of an electronic poster with clinical data from the AWARE-1...
From
PR Newswire
Oncolytics Biotech® Announces Abstract Publication and Upcoming Oral Presentation at the 2020 Society of Neuro-Oncology Annual Meeting
November 09, 2020
- Data from a phase 1b, investigator-sponsored study show that a pelareorep-based combination therapy is safe and well-tolerated in newly diagnosed glioblastoma multiforme patients
From
PR Newswire
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights
November 06, 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Wednesday, November 11, 2020, at 5:00 pm ET to discuss a corporate update and...
From
PR Newswire
Thinking about buying stock in Scholar Rock Holding, Electrameccanica Vehicles, Verastem, Oncolytics Biotech, or Cisco Systems?
October 29, 2020
InvestorsObserver issues critical PriceWatch Alerts for SRRK, SOLO, VSTM, ONCY, and CSCO.
From
PR Newswire
Thinking about buying stock in Tilray, Delta Air Lines, Norwegian Cruise Line, Oncolytics Biotech, or Marathon Oil?
October 27, 2020
InvestorsObserver issues critical PriceWatch Alerts for TLRY, DAL, NCLH, ONCY, and MRO.
From
PR Newswire
Why Gastrointestinal (GI) Cancer Drugs Are Expected to See Significant Growth Over Next Few Years
October 27, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Gastrointestinal (GI) Cancer Drugs Are Expected to See Significant Growth Over Next Few Years
October 27, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Oncolytics Biotech Collaborates with Roche and AIO to Initiate a Phase 1/2 Gastrointestinal Cancer Trial Combining Pelareorep with Roche’s Anti-PD-L1 Checkpoint Inhibitor
October 27, 2020
Tags
ONCY News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Oncolytics Biotech® Collaborates with Roche and AIO to Initiate a Phase 1/2 Gastrointestinal Cancer Trial Combining Pelareorep with Roche's Anti-PD-L1 Checkpoint Inhibitor
October 27, 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced a new multi-indication gastrointestinal (GI) cancer study to be managed by AIO, a leading academic cooperative medical oncology group...
From
PR Newswire
Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer
October 22, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer
October 22, 2020
FN Media Group Presents USA News Group News Commentary
From
PR Newswire
Oncolytics Biotech® Appoints Richard Vile, Ph.D., to its Scientific Advisory Board
October 19, 2020
World-renowned scientist specializing in oncolytic viruses and immuno-oncology
From
PR Newswire
Thinking about buying stock in Canopy Growth Corp, Plantronics, Carparts.Com, Oncolytics Biotech, or Carnival Corp?
October 12, 2020
InvestorsObserver issues critical PriceWatch Alerts for CGC, PLT, PRTS, ONCY, and CCL.
From
PR Newswire
New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%
October 08, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%
October 08, 2020
- FN Media Group Presents USA News Group News Commentary
From
PR Newswire
Oncolytics Biotech® to Participate in BIO Investor Forum Digital
October 07, 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that the Company will be participating in the BIO Investor Forum Digital, which is taking place virtually from October 13-15, 2020.
From
PR Newswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.